These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 19522856

  • 21. PET and PET/CT in pediatric oncology.
    Jadvar H, Connolly LP, Fahey FH, Shulkin BL.
    Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
    [Abstract] [Full Text] [Related]

  • 22. Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept.
    Bural GG, Torigian DA, Chamroonrat W, Alkhawaldeh K, Houseni M, El-Haddad G, Alavi A.
    Nucl Med Biol; 2006 Nov; 33(8):1037-43. PubMed ID: 17127178
    [Abstract] [Full Text] [Related]

  • 23. Incidental PET/CT findings in the cancer patient: how should they be managed?
    Beatty JS, Williams HT, Aldridge BA, Hughes MP, Vasudeva VS, Gucwa AL, David GS, Lind DS, Kruse EJ, McLoughlin JM.
    Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
    [Abstract] [Full Text] [Related]

  • 24. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow.
    Mullani NA, Herbst RS, O'Neil RG, Gould KL, Barron BJ, Abbruzzese JL.
    J Nucl Med; 2008 Apr; 49(4):517-23. PubMed ID: 18344436
    [Abstract] [Full Text] [Related]

  • 25. FDG PET and PET/CT monitoring of autoimmune pancreatitis associated with extrapancreatic autoimmune disease.
    Nakajo M, Jinnouchi S, Noguchi M, Uozumi K, Tanabe H, Tateno R, Nakajo M.
    Clin Nucl Med; 2007 Apr; 32(4):282-5. PubMed ID: 17413574
    [Abstract] [Full Text] [Related]

  • 26. Incidental inflammatory findings in nerves and in patients with neoplastic diseases evaluated by 18F-FDG-PET/CT.
    Bertagna F, Giubbini R, Biasiotto G, Rosenbaum J, Alavi A.
    Hell J Nucl Med; 2009 Apr; 12(3):279-80. PubMed ID: 19936345
    [No Abstract] [Full Text] [Related]

  • 27. PET/CT for therapy response assessment in lymphoma.
    Hutchings M, Barrington SF.
    J Nucl Med; 2009 May; 50 Suppl 1():21S-30S. PubMed ID: 19380407
    [Abstract] [Full Text] [Related]

  • 28. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M.
    J Clin Oncol; 2009 Jul 10; 27(20):3303-11. PubMed ID: 19451443
    [Abstract] [Full Text] [Related]

  • 29. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.
    Brix G, Lechel U, Glatting G, Ziegler SI, Münzing W, Müller SP, Beyer T.
    J Nucl Med; 2005 Apr 10; 46(4):608-13. PubMed ID: 15809483
    [Abstract] [Full Text] [Related]

  • 30. Physiologic thymic uptake of 18F-FDG in children and young adults: a PET/CT evaluation of incidence, patterns, and relationship to treatment.
    Jerushalmi J, Frenkel A, Bar-Shalom R, Khoury J, Israel O.
    J Nucl Med; 2009 Jun 10; 50(6):849-53. PubMed ID: 19443604
    [Abstract] [Full Text] [Related]

  • 31. Diagnosis and localization of renal cyst infection by 18F-fluorodeoxyglucose PET/CT in polycystic kidney disease.
    Soussan M, Sberro R, Wartski M, Fakhouri F, Pecking AP, Alberini JL.
    Ann Nucl Med; 2008 Jul 10; 22(6):529-31. PubMed ID: 18670861
    [Abstract] [Full Text] [Related]

  • 32. Considerations for generic oncology FDG-PET/CT protocol preparation in drug development.
    Hallett WA, Maguire RP, McCarthy TJ, Schmidt ME, Young H.
    IDrugs; 2007 Nov 10; 10(11):791-6. PubMed ID: 17968761
    [Abstract] [Full Text] [Related]

  • 33. Usefulness of F-18 FDG-PET in a long-term hemodialysis patient with renal cell carcinoma and pheochromocytoma.
    Ozawa N, Okamura T, Koyama K, Hamazawa Y, Senzaki H, Tanabe S, Ikemoto S, Inoue Y.
    Ann Nucl Med; 2007 Jun 10; 21(4):239-43. PubMed ID: 17581724
    [Abstract] [Full Text] [Related]

  • 34. Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
    Yamane T, Daimaru O, Ito S, Nagata T, Yoshiya K, Fukaya N, Ito S, Imai T, Uchida H.
    Ann Nucl Med; 2008 Oct 10; 22(8):719-22. PubMed ID: 18982476
    [Abstract] [Full Text] [Related]

  • 35. F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.
    Wiesenthal AA, Nguyen BD.
    Clin Nucl Med; 2007 Oct 10; 32(10):797-801. PubMed ID: 17885362
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Clinical, laboratory, radiological features, and outcome in 26 patients with aortic involvement amongst a case series of 63 patients with giant cell arteritis].
    Daumas A, Rossi P, Bernard-Guervilly F, Francès Y, Berbis J, Durand JM, Kaplanski G, Ebbo M, Harlé JR, Weiller PJ, Serratrice J, Disdier P, Gayet S, Villani P, Granel B.
    Rev Med Interne; 2014 Jan 10; 35(1):4-15. PubMed ID: 23906779
    [Abstract] [Full Text] [Related]

  • 38. PET in vasculitis.
    Blockmans D.
    Ann N Y Acad Sci; 2011 Jun 10; 1228():64-70. PubMed ID: 21718324
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Massive thyroid involvement by marginal zone B cell NHL as demonstrated by 18F-FDG-PET/CT.
    Bertagna F, Sobic-Saranovic D, Obradovic V, Artiko V, Giubbini R, Alavi A.
    Hell J Nucl Med; 2009 Jun 10; 12(1):63. PubMed ID: 19330187
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.